Overview

Study of NMS-1116354 in Solid Tumors

Status:
Terminated
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety profile of NMS-1116354, a CDC7 kinase inhibitor, in adult patients with advanced solid tumors.
Phase:
Phase 1
Details
Lead Sponsor:
Nerviano Medical Sciences